{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000345.4:c.88G>C",
          "cDNA Change": {
            "transcript": "NM_000345.4",
            "ref": "G",
            "alt": "C",
            "position": "88"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "P",
            "position": "30"
          },
          "Description in input context": "A30P"
        },
        {
          "HGVS": "NM_000345.4:c.136G>A",
          "cDNA Change": {
            "transcript": "NM_000345.4",
            "ref": "G",
            "alt": "A",
            "position": "136"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "K",
            "position": "46"
          },
          "Description in input context": "E46K"
        },
        {
          "HGVS": "NM_000345.4:c.157G>A",
          "cDNA Change": {
            "transcript": "NM_000345.4",
            "ref": "G",
            "alt": "A",
            "position": "157"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "A53T"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Dementia with Lewy Bodies",
    "MONDO": "MONDO:0011913"
  },
  "Experiment Method": [
    {
      "Assay Method": "Liposome Pull-Down Assay",
      "Material used": {
        "Material Source": "Recombinant Protein",
        "Material Name": "GST-fusion a-synuclein",
        "Description": "Recombinant GST-fusion protein (37.5 pmol) was bound to glutathione-agarose beads."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.88G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Mutation A30P reduced the binding of a-synuclein to type A liposomes by 95% and to type B liposomes by 53%."
        },
        {
          "Variant": "NM_000345.4:c.136G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Mutation E46K increased the binding of a-synuclein to type A liposomes by 88% and to type B liposomes by 56%."
        },
        {
          "Variant": "NM_000345.4:c.157G>A",
          "Conclusion": "Normal",
          "Molecular Effect": "No Effect",
          "Result Description": "Mutation A53T led to a non-significant 9-12% reduction in the binding of a-synuclein to both liposome types."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Measurements obtained from three independent protein preparations."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each run in duplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type GST-a-synuclein binding taken as 100%."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Non-specific binding due to GST bound to beads was subtracted."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Results expressed as means ± S.E.M."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Binding similar to wild-type a-synuclein (taken as 100%).",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significant deviation (>50% change) from wild-type a-synuclein binding.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Filament Assembly Assay (Thioflavin T Fluorescence)",
      "Material used": {
        "Material Source": "Recombinant Protein",
        "Material Name": "Untagged a-synuclein",
        "Description": "Untagged a-synuclein proteins were used at 400 µM in 30 mM Mops, pH 7.2."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.88G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "The rate of assembly of the A30P mutant was slower than for wild-type a-synuclein, but the amount of assembly was similar to that of the E46K and A53T mutants at 98 h."
        },
        {
          "Variant": "NM_000345.4:c.136G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "E46K a-synuclein showed a faster rate of assembly and a 2.5-fold greater total assembly than the wild-type protein at 98 h."
        },
        {
          "Variant": "NM_000345.4:c.157G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The A53T mutant behaved in a similar way to E46K a-synuclein with a faster rate of assembly."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Measurements obtained from three independent protein preparations."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type a-synuclein assembly used as reference."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Results expressed as means ± S.E.M."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Assembly rate and total assembly similar to wild-type a-synuclein.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significant increase or decrease in assembly rate or total assembly compared to wild-type a-synuclein.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Filament Assembly Assay (Electron Microscopy)",
      "Material used": {
        "Material Source": "Recombinant Protein",
        "Material Name": "Untagged a-synuclein",
        "Description": "Aliquots of assembly mixtures were placed on carbon-coated 400-mesh grids and stained with 1% potassium phosphotungstate."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.88G>C",
          "Conclusion": "Normal",
          "Molecular Effect": "No Effect",
          "Result Description": "Morphologies of filaments of A30P a-synucleins were very similar to wild-type, having a filament width of 6-9 nm."
        },
        {
          "Variant": "NM_000345.4:c.136G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Filaments assembled from E46K a-synuclein often showed a pronounced twisted appearance, with width varying between about 5 and 14 nm, and a cross-over spacing of about 43 nm."
        },
        {
          "Variant": "NM_000345.4:c.157G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Images of filaments made from the A53T mutant tended to show a more marked periodic variation in width between about 5 and 14 nm, giving a twisted appearance with a cross-over spacing of about 100 nm."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type a-synuclein filament morphology used as reference."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Filament morphology similar to wild-type a-synuclein (width of 6-9 nm with slight periodic variation).",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significant deviation in filament morphology (e.g., pronounced twisting or altered cross-over spacing) compared to wild-type a-synuclein.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}